Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated
Oculis (OCS) notified investors on Feb 18, 2026 that certain managerial transactions relate to the vesting of earnout shares and the associated removal of restrictions on those ordinary shares.
Rhea-AI Summary
Oculis (OCS) notified investors on Feb 18, 2026 that certain managerial transactions relate to the vesting of earnout shares and the associated removal of restrictions on those ordinary shares.
The notifications name four managers: Anthony Rosenberg, Pall Johannesson, Riad Sherif, and Sylvia Cheung.
Positive
- None.
Negative
- None.
Details
News Market Reaction – OCS
In the Feb 19 session, OCS declined 0.63%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Publication date
- Feb. 18, 2026
- Press release announcement of PDMR earnout share vesting
Historical Context
-
Highlighted late-stage ophthalmology pipeline and upcoming DIAMOND Phase 3 results.
-
FDA Breakthrough Therapy Designation for Privosegtor in optic neuritis.
-
Administrative notice of RSU vesting and settlement for a director.
-
Routine RSU vesting disclosures for four company directors.
-
Notification of RSU vesting for a single director.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
persons discharging managerial responsibilities regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
ZUG, Switzerland, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares.
Attachments
- Notification of managers' transaction - Anthony Rosenberg
- Notification of managers' transaction - Pall Johannesson
- Notification of managers' transaction - Riad Sherif
- Notification of managers' transaction - Sylvia Cheung